Abel Trujillo-Ocampo, Ph.D.
Department of Hematopoietic Biology & Malignancy, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Instructor, Department of Hematopoietic Biology and Malignancy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Instructor, Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2016 | Centro de Investigacion y de Estudios Evanzados del IPN,, CINVESTAV-IPN, MX, Immunology, Ph.D |
| 2011 | Centro de Investigacion y de Estudios Avanzados del IPN,, CINVESTAV-IPN, MX, Immunology, M.S |
| 2009 | Universidad Autonoma de Guerrero, Chilpancingo, MX, Chemistry, Biology Parasitology, BS |
Postgraduate Training
| 2017-2023 | Research Fellowship, Department of Stem Cells Transplantation/ Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas |
Experience & Service
Other Professional Positions
Postdoctoral Fellow, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023
Teacher, Justo Sierra University Cultural Center, Ciudad de México, 2016 - 2016
Honors & Awards
| 2022 - 2024 | New Investigator Award, American Society for Transplantation and Cellular Therapy (ASTCT) |
| 2021 - 2022 | Careers in Immunology Fellowships, American Association of Immunologists (AAI) |
| 2011 - 2015 | Ph.D. Degree Scholarship, Consejo Nacional de Humanidades, Ciencias y Tecnologias (CONACyT) |
| 2009 - 2011 | Master's Degree Scholarship, Consejo Nacional de Humanidades, Ciencias y Tecnologias (CONACyT) |
Selected Presentations & Talks
National Presentations
- 2024. Cord-Derived Invariant Natural Killer T Cells As Novel Cell Therapy to Improve the Outcome of Hematopoietic Stem Cell Transplantation. Poster, US.
- 2018. Ex vivo expansion of human iNKT cells for adoptive therapy-GVHD. Conference. Immunology department. Galveston, TX, US.
- 2017. Ex vivo expansion of iNKT cells for adoptive cell therapy. Poster. CD1-MR1 meeting. Napa, California, US.
International Presentations
- 2020. Investigation cord derived human invariant natural killer T cells as potential immune-regulators to prevent Graft Versus Host Disease. Invited. 30th DIPM Anniversary, session 6. Enfermedades cronico-degenerativas. Mexico City (on line), MX.
- 2018. Ex vivo expansion of iNKT cells as novel adoptive therapy to modulate GVHD. Invited. Juarez Hospital. Mexico city, MX.
- 2013. Advances and perspectives of flow cytometry. Invited. National Laboratory of Experimental Services (LaNSE). Mexico City, MX.
Formal Peers
- 2011. Cell cycle and apoptosis. Invited. Mexico City, MX.
Selected Publications
Peer-Reviewed Articles
- Trujillo-Ocampo A. Cord-Derived Inkt Cells are Enriched with Human NKT10s and Mediate Immune-Regulation via Neuropilin-1. e-Pub 2025.
- Maison Grefe, Trujillo-Ocampo A. Cord blood-derived iNK T cells as a platform for allogeneic CAR T cell therapy. Front Immunol, 2025. e-Pub 2025. PMID: 40519924.
- Raychaudhuri D, Singh P, Hennessey M, Chakraborty B, Tannir AJ, Trujillo-Ocampo A, Im JS, Goswami S. Histone Lactylation Drives CD8 T Cell Metabolism and Function. bioRxiv, 2024. e-Pub 2024. PMID: 38854142.
- Lee SE, Wang F, Grefe M, Trujillo-Ocampo A, Ruiz-Vasquez W, Takahashi K, Abbas HA, Borges P, Antunes DA, Al-Atrash G, Daver N, Molldrem JJ, Futreal A, Garcia-Manero G, Im JS. Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes. Clin Cancer Res 29(10):1938-1951, 2023. e-Pub 2023. PMID: 36988276.
- Pareek S, Flegle AS, Boagni D, Kim JY, Yoo D, Trujillo-Ocampo A, Lee SE, Zhang M, Jon S, Im JS. Post Transplantation Bilirubin Nanoparticles Ameliorate Murine Graft Versus Host Disease via a Reduction of Systemic and Local Inflammation. Front Immunol 13:893659, 2022. e-Pub 2022. PMID: 35720391.
- Lee SE, Wang F, Trujillo-Ocampo A, Ruiz-Vasquez W, Cho HW, Takahashi K, Molldrem JJ, Futreal A, Garcia-Manero G, Im JS. Fidelity of peripheral blood for monitoring genomics and tumor immune-microenvironment in myelodysplastic syndromes. EJHaem 1(2):552-557, 2020. e-Pub 2020. PMID: 35844984.
- Trujillo-Ocampo A, Cho HW, Clowers M, Pareek S, Ruiz-Vazquez W, Lee SE, Im JS. IL-7 During Antigenic Stimulation Using Allogeneic Dendritic Cells Promotes Expansion of CD45RA-CD62L+CD4+ Invariant NKT Cells With Th-2 Biased Cytokine Production Profile. Front Immunol 11:567406, 2020. e-Pub 2020. PMID: 33329531.
- Trujillo-Ocampo A, Cho HW, Herrmann AC, Ruiz-Vazquez W, Thornton AB, He H, Li D, Qazilbash MA, Ma Q, Porcelli SA, Shpall EJ, Molldrem J, Im JS. Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease. Cytotherapy 20(8):1089-1101, 2018. e-Pub 2018. PMID: 30076070.
- Trujillo-Ocampo A, Cázares-Raga FE, Del Angel RM, Medina-Ramírez F, Santos-Argumedo L, Rodríguez MH, Hernández-Hernández FC. Participation of 14-3-3ε and 14-3-3ζ proteins in the phagocytosis, component of cellular immune response, in Aedes mosquito cell lines. Parasit Vectors 10(1):362, 2017. e-Pub 2017. PMID: 28764795.
- González-López L, Carballar-Lejarazú R, Arrevillaga Boni G, Cortés-Martínez L, Cázares-Raga FE, Trujillo-Ocampo A, Rodríguez MH, James AA, Hernández-Hernández FC. Lys48 ubiquitination during the intraerythrocytic cycle of the rodent malaria parasite, Plasmodium chabaudi. PLoS One 12(6):e0176533, 2017. e-Pub 2017. PMID: 28604779.
- Trujillo-Ocampo A, Cázares-Raga FE, Celestino-Montes A, Cortés-Martínez L, Rodríguez MH, Hernández-Hernández FC. IDENTIFICATION AND EXPRESSION ANALYSIS OF TWO 14-3-3 PROTEINS IN THE MOSQUITO Aedes aegypti, AN IMPORTANT ARBOVIRUSES VECTOR. Arch Insect Biochem Physiol 93(3):143-159, 2016. e-Pub 2016. PMID: 27592842.
Other Articles
- Trujillo-Ocampo, A, Cho, HW, Pareek, S, RUIZ-VAZQUEZ, W, Clowers, MJ, Lee, SE, Im, JS Corrigendum. Frontiers in immunology 12, 2021. PMID: 33959134.
Abstracts
- Trujillo-Ocampo A. Cord-Derived Invariant Natural Killer T Cells As Novel Cell Therapy to Improve the Outcome of Hematopoietic Stem Cell Transplantation Blood (2024) 144 (Supplement 1): 4818. e-Pub 2024.
- al TE. LRP1-deficient T cells protect against acute Graft Versus Host Disease in MHC-Mismatched Mice. American society of hematologist, 2022. e-Pub 2022.
- al TE. Cord-derived human natural killer T cells are enriched with NKT10 subsets and ameliorate xeno Graft Versus Host Disease. Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021. e-Pub 2021.
- al TE. Ex Vivo expansion of iNKT cell for adoptive cell therapy. CD1-MR1 2017 meeting, Napa, California, USA, 2017. e-Pub 2017.
- al TE. Expression analysis and tissue distribution of 14-3-3 isoforms in Aedes aegypti. 13th INTERNATIONAL CONGRESS OF PARASITOLOGY, Mexico City, Mexico, 2014. e-Pub 2014.
- al TE. Identification and analysis of expression of 14-3-3 isoforms in Aedes aegypti. Seventh International Symposium on Molecular Insect Science, Amsterdam, The Netherland, 2014. e-Pub 2014.
- al TE. Production and characterization of polyclonal antibodies against CD38. The American Association of Immunologist AAI Annual meeting, San Francisco, California, USA, 2011. e-Pub 2011.
- Greife M, Trujillo-Ocampo A, Boagni D, Clinton J, He H, Clise-Dwyer K, Cho H, Shpall EJ, Molldrem JJ, Im SJ. Cord Derived 8F4CAR-iNKT Cells to Prevent Acute Myeloid Leukemia Relapse and Graft Vs. Host Disease after Allogeneic Stem Cell Transplantation. American Society of Hematology.
- Sizova, Li Dan, Ma Qing, St John Lisa, Clise-Dwyer K, Trujillo-Ocampo A, Molldrem JJ. LRP1-Deficient T Cells Protect Against Acute Graft Versus Host Disease in MHC-Mismatched Mice. American Society of Hematology.
- Trujillo-Ocampo A. Cord-Derived Invariant Natural Killer T Cells As Novel Cell Therapy to Improve the Outcome of Hematopoietic Stem Cell Transplantation. ASH.
Patient Reviews
CV information above last modified March 25, 2026